• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain.

作者信息

Dawood M Y, Khan-Dawood F S, Wilson L

出版信息

Am J Obstet Gynecol. 1984 Feb 15;148(4):391-5. doi: 10.1016/0002-9378(84)90713-0.

DOI:10.1016/0002-9378(84)90713-0
PMID:6364810
Abstract

Peritoneal fluid obtained at laparoscopy from 49 women was measured for its content of prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), 6-keto-prostaglandin F1 alpha (6-KF), and thromboxane B2 (TxB2) by specific radioimmunoassays. In normal women (n = 10), the concentrations of prostaglandins in peritoneal fluid were (mean +/- SE): PGE2 = 0.79 +/- 0.26, PGF2 alpha = 0.60 +/- 0.18, 6-KF = 0.48 +/- 0.19, and TxB2 = 0.23 +/- 0.09 ng/ml; in women with endometriosis (n = 16): PGE2 = 1.43 +/- 0.72, PGF2 alpha = 1.52 +/- 0.59, 6-KF = 3.32 +/- 0.71, and TxB2 = 1.14 +/- 0.69 ng/ml; in women with chronic pelvic inflammatory disease and/or obstructed tubes (n = 19): PGE2 = 1.94 +/- 1.04, PGF2 alpha = 1.20 +/- 0.61, 6-KF = 1.55 +/- 0.40, and TxB2 = 0.64 +/- 0.24 ng/ml; in women with pelvic pain without any visible pathologic condition (n = 4): PGE2 = 1.11 +/- 0.66, PGF2 alpha = 0.73 +/- 0.55, 6-KF = 1.35 +/- 0.35, and TxB2 = 0.39 +/- 0.17. The mean volumes of peritoneal fluid recovered were 10 to 16 ml and were not significantly different between the groups. Except for a significantly elevated concentration of 6-KF in the peritoneal fluid of women with endometriosis compared to normal women (p = less than 0.02), the prostaglandins measured did not differ significantly between the groups of women studied. The possible significance of elevated 6-KF in the peritoneal fluid of women with endometriosis is discussed.

摘要

相似文献

1
Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain.
Am J Obstet Gynecol. 1984 Feb 15;148(4):391-5. doi: 10.1016/0002-9378(84)90713-0.
2
[Prostanoids of the peritoneal fluid and sterility with or without pelvic lesions (endometriosis, postinfectious adhesions)].[腹膜液中的前列腺素与有无盆腔病变(子宫内膜异位症、感染后粘连)的不育症]
Pathol Biol (Paris). 1986 Feb;34(2):101-7.
3
Follicular fluid prostaglandins in endometriosis and ovarian hyperstimulation.
Fertil Steril. 1984 Jan;41(1):66-9. doi: 10.1016/s0015-0282(16)47543-6.
4
Prostanoids in peritoneal fluid of infertile women with pelvic endometriosis and PID.
Acta Eur Fertil. 1987 May-Jun;18(3):189-92.
5
PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis.子宫内膜异位症中人类腹膜巨噬细胞释放前列腺素E2和前列腺素F2α
Prostaglandins. 1996 Jan;51(1):49-60. doi: 10.1016/0090-6980(95)00159-x.
6
Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis.患有和未患有子宫内膜异位症患者的腹腔液体积、雌激素、孕激素、前列腺素和表皮生长因子浓度。
Obstet Gynecol. 1986 Aug;68(2):189-94.
7
The concentration of 13,14-dihydro-15-keto prostaglandin F2 alpha and prostaglandin E2 in peritoneal fluid of infertile patients with and without endometriosis.
Fertil Steril. 1982 Aug;38(2):166-70. doi: 10.1016/s0015-0282(16)46453-8.
8
Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis.月经周期各阶段的腹腔液前列腺素:在子宫内膜异位症不孕患者中的作用
Int J Fertil. 1985;30(2):48-52.
9
The prostanoid content in peritoneal fluid and plasma of women with endometriosis.子宫内膜异位症女性腹膜液和血浆中的前列腺素含量。
Am J Obstet Gynecol. 1983 Nov 1;147(5):563-5. doi: 10.1016/0002-9378(83)90017-0.
10
Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle--days 8 to 12.患有子宫内膜异位症女性的直肠子宫陷凹积液:月经周期增殖期(第8至12天)的液体量和前列腺素浓度
Fertil Steril. 1982 Jun;37(6):747-50. doi: 10.1016/s0015-0282(16)46332-6.

引用本文的文献

1
Endometriosis and Cytoskeletal Remodeling: The Functional Role of Actin-Binding Proteins.子宫内膜异位症与细胞骨架重塑:肌动蛋白结合蛋白的功能作用
Cells. 2025 Feb 28;14(5):360. doi: 10.3390/cells14050360.
2
Endometriosis and aspirin: a systematic review.子宫内膜异位症与阿司匹林:系统综述。
Front Endocrinol (Lausanne). 2024 Aug 27;15:1409469. doi: 10.3389/fendo.2024.1409469. eCollection 2024.
3
Endometriosis-Related Chronic Pelvic Pain.子宫内膜异位症相关的慢性盆腔疼痛
Biomedicines. 2023 Oct 23;11(10):2868. doi: 10.3390/biomedicines11102868.
4
Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages.选择性 PGE2 受体拮抗剂对人子宫内膜间质细胞和腹腔巨噬细胞的作用。
Mol Hum Reprod. 2021 Jan 22;27(1). doi: 10.1093/molehr/gaaa077.
5
Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis.子宫内膜异位症患者中前列腺素E2和F2α受体及转运体的异常表达
Biomed Res Int. 2015;2015:808146. doi: 10.1155/2015/808146. Epub 2015 Jul 9.
6
Chronic pelvic pain in endometriosis: an overview.子宫内膜异位症中的慢性盆腔疼痛:综述
J Clin Med Res. 2013 Jun;5(3):153-63. doi: 10.4021/jocmr1288w. Epub 2013 Apr 23.
7
Immune interactions in endometriosis.子宫内膜异位症中的免疫相互作用。
Expert Rev Clin Immunol. 2011 Sep;7(5):611-26. doi: 10.1586/eci.11.53.
8
Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.前列腺素E2对腹膜巨噬细胞中基质金属蛋白酶-9的抑制作用与子宫内膜异位症的严重程度相关。
Am J Pathol. 2005 Oct;167(4):1061-9. doi: 10.1016/S0002-9440(10)61195-9.
9
Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model.使用一种新的细胞培养模型鉴定子宫内膜异位症中一种侵袭性的、表达N-钙黏蛋白的上皮细胞类型。
Am J Pathol. 2001 Nov;159(5):1839-52. doi: 10.1016/S0002-9440(10)63030-1.
10
Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.卵巢恶性肿瘤患者中前列环素和血栓素降解产物的尿排泄:细胞抑制治疗的影响
Br J Cancer. 1989 Nov;60(5):785-8. doi: 10.1038/bjc.1989.360.